News Daily News Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds L.A. McKeown February 23, 2024
News Conference News AHA 2023 Seeing Sticker Price for HFrEF Meds Opens Door to Discussions Caitlin E. Cox November 14, 2023
News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Conference News TCT 2023 TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER Yael L. Maxwell October 26, 2023
News Daily News First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists L.A. McKeown August 31, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023
News Conference News ESC Heart Failure 2023 More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF Shelley Wood May 22, 2023
News Daily News Generic Dabigatran Lots Pulled for Nitrosamine Impurity Michael O'Riordan March 28, 2023
News Daily News Study Debunks Obesity Paradox in HF, Encourages BMI Alternatives L.A. McKeown March 24, 2023
News Conference News THT 2023 Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF Todd Neale March 21, 2023
News Conference News ACC 2023 COAPT at 5 Years: MitraClip Still Ahead, but Deaths and Crossovers Cast Shadows Shelley Wood March 05, 2023
News Conference News ACC 2023 TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR Todd Neale March 04, 2023
News Daily News Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs Todd Neale January 23, 2023
News Daily News HFrEF’s Financial Burden May Get Relief From Inflation Reduction Act L.A. McKeown January 13, 2023
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022
News Conference News AHA 2022 TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF Todd Neale November 05, 2022
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Conference News ESC 2022 No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE Shelley Wood August 26, 2022
News Daily News Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds Shelley Wood July 25, 2022